FDA clears first digital treatment for depression, but experts caution that research is still early


Sorry didn’t read the article

What exactly is it?

Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, is a smartphone app intended for use alongside antidepressant medications for people 22 and older who have a diagnosis of major depressive disorder. It employs a six-week program that combines a new approach called cognitive-emotional training and cognitive behavioral therapy lessons, according to a news release.

1 Like

Very cool I wonder if it’s available here. I’ll have to look it up. Thanks for sharing dude.

1 Like